Cancer BiologybioRxivPreprint
Tumor neoantigen heterogeneity thresholds provide a time window for combination immunotherapy
This paper develops a mathematical framework to show that tumor neoantigen heterogeneity affects immune response, with a diversity threshold beyond which T cells fail to control cancer growth, suggesting a time window for combination immunotherapy.
DOI 10.1101/823856